VASCULONICS INC
A first-in-class disease modifying therapy for PAH and CKD patients
Washington, United States · Founded 2019
- Headquarters
- Washington, District of Columbia
- Founded
- 2019
- Business Model
- B2G
- Website
- vasculonics.com
About
Vasculonics is a therapeutic development company pioneering a first-in-class disease-modifying drug for pulmonary arterial hypertension (PAH) and chronic kidney disease (CKD). The company develops Selective Aryl Hydrocarbon Receptor Modulators (SAhRM), with lead compound VN-1032 targeting inflammation, oxidative stress, and fibrosis. Vasculonics has secured over $5 million in federal grants including NIH NHLBI SBIR Phase I/II and BARDA Blue Knight awards.
Summary
VASCULONICS INC is a Biotech company based in Washington, United States, founded in 2019.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vasculonics-inc"><img src="https://indexed.vc/api/badge/company/vasculonics-inc" alt="VASCULONICS INC on Indexed.vc" width="260" height="76" /></a>